glp-1 lizard saliva Curious how a slow-moving sparked one of the biggest pharmaceutical breakthroughs of our time? The blockbuster drugs behind today's diabetes and weight-loss treatments have an origin story few people know A quick Google search says

[ii] Krger, E., Shatokhina, E

Anti-inflammatory properties of NRF2 signaling have been verified in LPS-stimulated mouse microglia, where its upregulation reduced inflammatory markers (Townsend and Johnson, 2016) and astrocytic, and microglial activation were found to be significantly lower (Jing et al., 2015)

Not for human use or therapeutic consumption

This hormone helps sustain your normal body structure and crucial metabolic processes

While these drugs are highly effective for weight loss and glycemic control, they are associated with gastrointestinal issues such as nausea, vomiting, and diarrhea, which can lead to treatment discontinuation among some patients For instance, clinical data and patient reports have shown that adverse events are particularly common during the early stages of treatment with drugs such as semaglutide and tirzepatide, prompting careful dose titration and medical supervision, which may not be feasible for all patients or healthcare settings Addressing these side effect concerns through better patient education, physician training, and next-generation formulations with reduced tolerability issues is crucial to improving long-term adherence and treatment outcomes